Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Thaker, GK; Carpenter, WT
   Advances in schizophrenia
   NATURE MEDICINE
   
   G.K. Thaker e W.T. Carpenter, "Advances in schizophrenia", NAT MED, 7(6), 2001, pp. 667-671
2. Avila, MT; Conley, RR; Carpenter, WT
   A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research
   BIOLOGICAL PSYCHIATRY
   
   M.T. Avila et al., "A comparison of symptom provocation procedures in psychiatry and other areas of medicine: Implications for their ethical use in research", BIOL PSYCHI, 50(7), 2001, pp. 479-486
3. Kirkpatrick, B; Buchanan, RW; Ross, DE; Carpenter, WT
   A separate disease within the syndrome of schizophrenia
   ARCHIVES OF GENERAL PSYCHIATRY
   
   B. Kirkpatrick et al., "A separate disease within the syndrome of schizophrenia", ARCH G PSYC, 58(2), 2001, pp. 165-171
4. Carpenter, WT
   Evidence-based treatment for first-episode schizophrenia?
   AMERICAN JOURNAL OF PSYCHIATRY
   
   W.T. Carpenter, "Evidence-based treatment for first-episode schizophrenia?", AM J PSYCHI, 158(11), 2001, pp. 1771-1773
5. Lahti, AC; Holcomb, HH; Medoff, DR; Weiler, MA; Tamminga, CA; Carpenter, WT
   Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task
   AMERICAN JOURNAL OF PSYCHIATRY
   
   A.C. Lahti et al., "Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task", AM J PSYCHI, 158(11), 2001, pp. 1797-1808
6. Breier, A; Buchanan, RW; Irish, D; Carpenter, WT
   Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns
   PSYCHIATRIC SERVICES
   
   A. Breier et al., "Clozapine treatment of outpatients with schizophrenia: Outcome and long-term response patterns", PSYCH SERV, 51(10), 2000, pp. 1249-1253
7. Carpenter, WT; Breier, A; Buchanan, RW; Kirkpatrick, B; Shepard, P; Weiner, E
   Mazindol treatment of negative symptoms
   NEUROPSYCHOPHARMACOLOGY
   
   W.T. Carpenter et al., "Mazindol treatment of negative symptoms", NEUROPSYCH, 23(4), 2000, pp. 365-374
8. Carpenter, WT; Conley, R; Kirkpatrick, B
   On schizophrenia and new generation drugs
   NEUROPSYCHOPHARMACOLOGY
   
   W.T. Carpenter et al., "On schizophrenia and new generation drugs", NEUROPSYCH, 22(6), 2000, pp. 660-661
9. Kirkpatrick, B; Kopelowicz, A; Buchanan, RW; Carpenter, WT
   Assessing the efficacy of treatments for the deficit syndrome of schizophrenia
   NEUROPSYCHOPHARMACOLOGY
   
   B. Kirkpatrick et al., "Assessing the efficacy of treatments for the deficit syndrome of schizophrenia", NEUROPSYCH, 22(3), 2000, pp. 303-310
10. Kirkpatrick, B; Castle, D; Murray, RM; Carpenter, WT
    Risk factors for the deficit syndrome of schizophrenia
    SCHIZOPHRENIA BULLETIN
    
    B. Kirkpatrick et al., "Risk factors for the deficit syndrome of schizophrenia", SCHIZO BULL, 26(1), 2000, pp. 233-242
11. Carpenter, WT; Gold, JM; Lahti, AC; Queern, CA; Conley, RR; Bartko, JJ; Kovnick, J; Appelbaum, PS
    Decisional capacity for informed consent in schizophrenia research
    ARCHIVES OF GENERAL PSYCHIATRY
    
    W.T. Carpenter et al., "Decisional capacity for informed consent in schizophrenia research", ARCH G PSYC, 57(6), 2000, pp. 533-538
12. Carpenter, WT; Conley, RR
    Sense and nonsense: an essay on schizophrenia research ethics
    SCHIZOPHRENIA RESEARCH
    
    W.T. Carpenter e R.R. Conley, "Sense and nonsense: an essay on schizophrenia research ethics", SCHIZOPHR R, 35(3), 1999, pp. 219-225
13. Arango, C; Carpenter, WT; Queern, CA
    Research ethics: A psychological approach.
    CLINICAL PSYCHOLOGY REVIEW
    
    C. Arango et al., "Research ethics: A psychological approach.", CLIN PSYCH, 19(3), 1999, pp. 384-385
14. Carpenter, WT; Kirkpatrick, B; Buchanan, RW
    Schizophrenia: syndromes and diseases
    JOURNAL OF PSYCHIATRIC RESEARCH
    
    W.T. Carpenter et al., "Schizophrenia: syndromes and diseases", J PSYCH RES, 33(6), 1999, pp. 473-475
15. Carpenter, WT
    The schizophrenia ketamine challenge study debate
    BIOLOGICAL PSYCHIATRY
    
    W.T. Carpenter, "The schizophrenia ketamine challenge study debate", BIOL PSYCHI, 46(8), 1999, pp. 1081-1091
16. Carpenter, WT; Arango, C; Buchanan, RW; Kirkpatrick, B
    Deficit psychopathology and a paradigm shift in schizophrenia research
    BIOLOGICAL PSYCHIATRY
    
    W.T. Carpenter et al., "Deficit psychopathology and a paradigm shift in schizophrenia research", BIOL PSYCHI, 46(3), 1999, pp. 352-360
17. Carpenter, WT; Zito, JM; Volavka, J
    Dopamine, receptor occupancy and the action of clozapine: Does it make a difference to add a neuroleptic? Reply
    BIOLOGICAL PSYCHIATRY
    
    W.T. Carpenter et al., "Dopamine, receptor occupancy and the action of clozapine: Does it make a difference to add a neuroleptic? Reply", BIOL PSYCHI, 46(1), 1999, pp. 147-149
18. Carpenter, WT
    The challenge to psychiatry as society's agent for mental illness treatment and research
    AMERICAN JOURNAL OF PSYCHIATRY
    
    W.T. Carpenter, "The challenge to psychiatry as society's agent for mental illness treatment and research", AM J PSYCHI, 156(9), 1999, pp. 1307-1310
19. Rafal, S; Tsuang, MT; Carpenter, WT
    A dilemma born of progress: Switching from clozapine to a newer antipsychotic
    AMERICAN JOURNAL OF PSYCHIATRY
    
    S. Rafal et al., "A dilemma born of progress: Switching from clozapine to a newer antipsychotic", AM J PSYCHI, 156(7), 1999, pp. 1086-1090
20. Arango, C; Adami, H; Sherr, JD; Thaker, GK; Carpenter, WT
    Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness
    AMERICAN JOURNAL OF PSYCHIATRY
    
    C. Arango et al., "Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness", AM J PSYCHI, 156(7), 1999, pp. 1097-1099
21. Amador, XF; Kirkpatrick, B; Buchanan, RW; Carpenter, WT; Marcinko, L; Yale, SA
    Stability of the diagnosis of deficit syndrome in schizophrenia
    AMERICAN JOURNAL OF PSYCHIATRY
    
    X.F. Amador et al., "Stability of the diagnosis of deficit syndrome in schizophrenia", AM J PSYCHI, 156(4), 1999, pp. 637-639
22. Carpenter, WT; Buchanan, RW; Kirkpatrick, B; Lann, HD; Breier, AF; Summerfelt, AT
    Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks
    AMERICAN JOURNAL OF PSYCHIATRY
    
    W.T. Carpenter et al., "Comparative effectiveness of fluphenazine decanoate injections every 2 weeks versus every 6 weeks", AM J PSYCHI, 156(3), 1999, pp. 412-418
23. Carpenter, WT; Buchanan, RW; Kirkpatrick, B; Breier, AF
    Diazepam treatment of early signs of exacerbation in schizophrenia
    AMERICAN JOURNAL OF PSYCHIATRY
    
    W.T. Carpenter et al., "Diazepam treatment of early signs of exacerbation in schizophrenia", AM J PSYCHI, 156(2), 1999, pp. 299-303
24. CARPENTER WT
    ETHICAL PROBLEMS IN PSYCHIATRIC RESEARCH
    JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH
    
    W.T. Carpenter, "ETHICAL PROBLEMS IN PSYCHIATRIC RESEARCH", JOURNAL OF BEHAVIORAL HEALTH SERVICES & RESEARCH, 25(4), 1998, pp. 465-466
25. HONG WW; RAK IW; CIURYLA VT; WILSON AM; KYLSTRA JW; MELTZER HY; CARPENTER WT; LEHMAN A; ARVANITIS LA
    MEDICAL-CLAIMS DATABASES IN THE DESIGN OF A HEALTH-OUTCOMES COMPARISON OF QUETIAPINE (SEROQUEL) AND USUAL-CARE ANTIPSYCHOTIC MEDICATION
    Schizophrenia research
    
    W.W. Hong et al., "MEDICAL-CLAIMS DATABASES IN THE DESIGN OF A HEALTH-OUTCOMES COMPARISON OF QUETIAPINE (SEROQUEL) AND USUAL-CARE ANTIPSYCHOTIC MEDICATION", Schizophrenia research, 32(1), 1998, pp. 51-58
26. CARPENTER WT
    MEDICATION-FREE RESEARCH AND PATIENT SAFETY
    Schizophrenia bulletin
    
    W.T. Carpenter, "MEDICATION-FREE RESEARCH AND PATIENT SAFETY", Schizophrenia bulletin, 24(1), 1998, pp. 35-36
27. CARPENTER WT
    NEW VIEWS ON THE COURSE AND TREATMENT OF SCHIZOPHRENIA
    Journal of Psychiatric Research
    
    W.T. Carpenter, "NEW VIEWS ON THE COURSE AND TREATMENT OF SCHIZOPHRENIA", Journal of Psychiatric Research, 32(3-4), 1998, pp. 191-195
28. CARPENTER WT; ZITO JM; VITRAI J; VOLAVKA J
    HYPOTHESIS-TESTING - IS CLOZAPINES SUPERIOR EFFICACY DEPENDENT ON MODERATE D-2 RECEPTOR OCCUPANCY
    Biological psychiatry
    
    W.T. Carpenter et al., "HYPOTHESIS-TESTING - IS CLOZAPINES SUPERIOR EFFICACY DEPENDENT ON MODERATE D-2 RECEPTOR OCCUPANCY", Biological psychiatry, 43(2), 1998, pp. 79-83
29. CARPENTER WT; SCHOOLER NR; KANE JM
    MEDICATION REMOVAL AND RESEARCH IN PSYCHOTIC DISORDERS - IN REPLY
    Archives of general psychiatry
    
    W.T. Carpenter et al., "MEDICATION REMOVAL AND RESEARCH IN PSYCHOTIC DISORDERS - IN REPLY", Archives of general psychiatry, 55(3), 1998, pp. 283-283
30. BUCHANAN RW; BREIER A; KIRKPATRICK B; BALL P; CARPENTER WT
    POSITIVE AND NEGATIVE SYMPTOM RESPONSE TO CLOZAPINE IN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT THE DEFICIT SYNDROME
    The American journal of psychiatry
    
    R.W. Buchanan et al., "POSITIVE AND NEGATIVE SYMPTOM RESPONSE TO CLOZAPINE IN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT THE DEFICIT SYNDROME", The American journal of psychiatry, 155(6), 1998, pp. 751-760
31. Carpenter, WT; Conley, RR; Buchanan, RW
    Schizophrenia
    PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
    
    W.T. Carpenter et al., "Schizophrenia", PHARMACOLOGICAL MANAGEMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, 1998, pp. 27-51
32. CARPENTER WT
    ARE PSYCHOPATHOLOGICAL DOMAINS INDEPENDENT DISEASES
    Schizophrenia research
    
    W.T. Carpenter, "ARE PSYCHOPATHOLOGICAL DOMAINS INDEPENDENT DISEASES", Schizophrenia research, 24(1-2), 1997, pp. 12-12
33. VLADAR K; BUCHANAN RW; CARPENTER WT; BARTA PE; PEARLSON GD
    PREFRONTAL CORTEX IN SCHIZOPHRENIA - A MAGNETIC-RESONANCE-IMAGING STUDY USING ANATOMICALLY RELEVANT LANDMARKS
    Schizophrenia research
    
    K. Vladar et al., "PREFRONTAL CORTEX IN SCHIZOPHRENIA - A MAGNETIC-RESONANCE-IMAGING STUDY USING ANATOMICALLY RELEVANT LANDMARKS", Schizophrenia research, 24(1-2), 1997, pp. 159-159
34. LAHTI AC; HOLCOMB HH; CARPENTER WT; ZHAO M; BUCHANAN RW; TAMMINGA CA
    BLOOD-FLOW ACTIVATION DIFFERENCES DURING AN AUDITORY TASK IN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT PRIMARY NEGATIVE SYMPTOMS
    Schizophrenia research
    
    A.C. Lahti et al., "BLOOD-FLOW ACTIVATION DIFFERENCES DURING AN AUDITORY TASK IN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT PRIMARY NEGATIVE SYMPTOMS", Schizophrenia research, 24(1-2), 1997, pp. 167-167
35. BUCHANAN RW; STEVENS JR; CARPENTER WT
    THE NEUROANATOMY OF SCHIZOPHRENIA - INTRODUCTION
    Schizophrenia bulletin
    
    R.W. Buchanan et al., "THE NEUROANATOMY OF SCHIZOPHRENIA - INTRODUCTION", Schizophrenia bulletin, 23(3), 1997, pp. 365-366
36. BUCHANAN RW; CARPENTER WT
    THE NEUROANATOMIES OF SCHIZOPHRENIA
    Schizophrenia bulletin
    
    R.W. Buchanan e W.T. Carpenter, "THE NEUROANATOMIES OF SCHIZOPHRENIA", Schizophrenia bulletin, 23(3), 1997, pp. 367-372
37. CARPENTER WT
    THE RISK OF MEDICATION-FREE RESEARCH
    Schizophrenia bulletin
    
    W.T. Carpenter, "THE RISK OF MEDICATION-FREE RESEARCH", Schizophrenia bulletin, 23(1), 1997, pp. 11-18
38. LAHTI AC; HOLCOMB HH; CARPENTER WT; ZHAO M; WEILER MA; COREY PK; MEDOFF D; BUCHANAN RW; TAMMINGA CA
    RCBF PATTERN DIFFERENCES BETWEEN DEFICIT AND NONDEFICIT SCHIZOPHRENIC-PATIENTS
    Biological psychiatry
    
    A.C. Lahti et al., "RCBF PATTERN DIFFERENCES BETWEEN DEFICIT AND NONDEFICIT SCHIZOPHRENIC-PATIENTS", Biological psychiatry, 41, 1997, pp. 215-215
39. CARPENTER WT; SCHOOLER NR; KANE JM
    THE RATIONALE AND ETHICS OF MEDICATION-FREE RESEARCH IN SCHIZOPHRENIA
    Archives of general psychiatry
    
    W.T. Carpenter et al., "THE RATIONALE AND ETHICS OF MEDICATION-FREE RESEARCH IN SCHIZOPHRENIA", Archives of general psychiatry, 54(5), 1997, pp. 401-407
40. CONLEY RR; CARPENTER WT; TAMMINGA CA
    TIME TO CLOZAPINE RESPONSE IN A STANDARDIZED TRIAL
    The American journal of psychiatry
    
    R.R. Conley et al., "TIME TO CLOZAPINE RESPONSE IN A STANDARDIZED TRIAL", The American journal of psychiatry, 154(9), 1997, pp. 1243-1247
41. BUSTILLO JR; THAKER G; BUCHANAN RW; MORAN M; KIRKPATRICK B; CARPENTER WT
    VISUAL INFORMATION-PROCESSING IMPAIRMENTS IN DEFICIT AND NONDEFICIT SCHIZOPHRENIA
    The American journal of psychiatry
    
    J.R. Bustillo et al., "VISUAL INFORMATION-PROCESSING IMPAIRMENTS IN DEFICIT AND NONDEFICIT SCHIZOPHRENIA", The American journal of psychiatry, 154(5), 1997, pp. 647-654
42. BUCHANAN RW; STRAUSS ME; BREIER A; KIRKPATRICK B; CARPENTER WT
    ATTENTIONAL IMPAIRMENTS IN DEFICIT AND NONDEFICIT FORMS OF SCHIZOPHRENIA
    The American journal of psychiatry
    
    R.W. Buchanan et al., "ATTENTIONAL IMPAIRMENTS IN DEFICIT AND NONDEFICIT FORMS OF SCHIZOPHRENIA", The American journal of psychiatry, 154(3), 1997, pp. 363-370
43. BUCHANAN RW; CARPENTER WT
    TARGETED MAINTENANCE TREATMENT IN SCHIZOPHRENIA - ISSUES AND RECOMMENDATIONS
    CNS DRUGS
    
    R.W. Buchanan e W.T. Carpenter, "TARGETED MAINTENANCE TREATMENT IN SCHIZOPHRENIA - ISSUES AND RECOMMENDATIONS", CNS DRUGS, 5(4), 1996, pp. 240-245
44. KIRKPATRICK B; AMADOR XF; FLAUM M; YALE SA; GORMAN JM; CARPENTER WT; TOHEN M; MCGLASHAN T
    THE DEFICIT SYNDROME IN THE DSM-IV FIELD TRIAL .1. ALCOHOL AND OTHER DRUG-ABUSE
    Schizophrenia research
    
    B. Kirkpatrick et al., "THE DEFICIT SYNDROME IN THE DSM-IV FIELD TRIAL .1. ALCOHOL AND OTHER DRUG-ABUSE", Schizophrenia research, 20(1-2), 1996, pp. 69-77
45. LAHTI AC; HOLCOMB HH; CARPENTER WT; CAUDILL PJ; ZHAO M; ALBERT PK; MEDOFF DR; TAMMINGA CA
    RCBF PATTERN DIFFERENCES BETWEEN MEDICATION-FREE SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT DEFICIT SYMPTOMS
    Schizophrenia research
    
    A.C. Lahti et al., "RCBF PATTERN DIFFERENCES BETWEEN MEDICATION-FREE SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT DEFICIT SYMPTOMS", Schizophrenia research, 18(2-3), 1996, p.
46. HOLCOMB HH; LAHTI AC; CAUDILL PJ; ZHAO Z; MEDOFF DR; CARPENTER WT; ALBERT PK; TAMMINGA CA
    RCBF PATTERN CONTRASTS BETWEEN NORMAL VOLUNTEERS AND MEDICATION-FREE SCHIZOPHRENICS DERIVED FROM A DIFFICULT TONE RECOGNITION TASK
    Schizophrenia research
    
    H.H. Holcomb et al., "RCBF PATTERN CONTRASTS BETWEEN NORMAL VOLUNTEERS AND MEDICATION-FREE SCHIZOPHRENICS DERIVED FROM A DIFFICULT TONE RECOGNITION TASK", Schizophrenia research, 18(2-3), 1996, p.
47. AMADOR XF; KIRKPATRICK B; CARPENTER WT; YALE SA; MARCINKO L
    THE LONG-TERM STABILITY OF THE DEFICIT SYNDROME
    Schizophrenia research
    
    X.F. Amador et al., "THE LONG-TERM STABILITY OF THE DEFICIT SYNDROME", Schizophrenia research, 18(2-3), 1996, pp. 4-4
48. CARPENTER WT
    MAINTENANCE THERAPY OF PERSONS WITH SCHIZOPHRENIA
    The Journal of clinical psychiatry
    
    W.T. Carpenter, "MAINTENANCE THERAPY OF PERSONS WITH SCHIZOPHRENIA", The Journal of clinical psychiatry, 57, 1996, pp. 10-18
49. CARPENTER WT; MCGUFFIN P; MELLOR CS; TORREY EF; OGRADY J; GEDDES JR; CHRISTOFI G; SACKETT DL; WING J; HAFNER H; CROW TJ
    FIRST-RANK SYMPTOMS OR RANK-AND-FILE SYMPTOMS - COMMENTARY
    British Journal of Psychiatry
    
    W.T. Carpenter et al., "FIRST-RANK SYMPTOMS OR RANK-AND-FILE SYMPTOMS - COMMENTARY", British Journal of Psychiatry, 169(5), 1996, pp. 541-542
50. CARPENTER WT
    TREATMENT OF NEGATIVE SYMPTOMS - PHARMACOLOGICAL AND METHODOLOGICAL ISSUES
    British Journal of Psychiatry
    
    W.T. Carpenter, "TREATMENT OF NEGATIVE SYMPTOMS - PHARMACOLOGICAL AND METHODOLOGICAL ISSUES", British Journal of Psychiatry, 168, 1996, pp. 17-22
51. CARPENTER WT; CONLEY RR; BUCHANAN RW; BREIER A; TAMMINGA CA
    CLOZAPINE CONFLICT
    The American journal of psychiatry
    
    W.T. Carpenter et al., "CLOZAPINE CONFLICT", The American journal of psychiatry, 153(11), 1996, pp. 1505-1507
52. CARPENTER WT; BUCHANAN RW; KIRKPATRICK B
    NEW DIAGNOSTIC ISSUES IN SCHIZOPHRENIC DISORDERS
    Clinical neuroscience
    
    W.T. Carpenter et al., "NEW DIAGNOSTIC ISSUES IN SCHIZOPHRENIC DISORDERS", Clinical neuroscience, 3(2), 1995, pp. 57-63
53. KIRKPATRICK B; AMADOR X; YALE S; GORMAN JM; CARPENTER WT
    DRUG-ABUSE AMONG DEFICIT AND NONDEFICIT SCHIZOPHRENIC-PATIENTS IN THEDSM-IV FIELD TRIALS
    Schizophrenia research
    
    B. Kirkpatrick et al., "DRUG-ABUSE AMONG DEFICIT AND NONDEFICIT SCHIZOPHRENIC-PATIENTS IN THEDSM-IV FIELD TRIALS", Schizophrenia research, 15(1-2), 1995, pp. 13-13
54. WALTRIP RW; BUCHANAN RW; SUMMERFELT A; BREIER A; CARPENTER WT; BRYANT NL; KIRKPATRICK B; RUBIN SA; CARBONE KM
    BORNA-DISEASE VIRUS-ANTIBODIES AND SCHIZOPHRENIA
    Schizophrenia research
    
    R.W. Waltrip et al., "BORNA-DISEASE VIRUS-ANTIBODIES AND SCHIZOPHRENIA", Schizophrenia research, 15(1-2), 1995, pp. 73-73
55. LAHTI AC; TAMMINGA CA; HOLCOMB HH; CAUDILL PJ; ZHAO M; MEDOFF DR; CARPENTER WT
    RCBF PATTERN DIFFERENCES BETWEEN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT ENDURING NEGATIVE SYMPTOMS (DEFICIT SYMPTOMS)
    Schizophrenia research
    
    A.C. Lahti et al., "RCBF PATTERN DIFFERENCES BETWEEN SCHIZOPHRENIC-PATIENTS WITH AND WITHOUT ENDURING NEGATIVE SYMPTOMS (DEFICIT SYMPTOMS)", Schizophrenia research, 15(1-2), 1995, pp. 89-89
56. BUCHANAN RW; CARPENTER WT; KIRKPATRICK B; BRYANT N; BUSTILLO J
    DOPAMINE AGENTS FOR THE TREATMENT OF THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
    Schizophrenia research
    
    R.W. Buchanan et al., "DOPAMINE AGENTS FOR THE TREATMENT OF THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA", Schizophrenia research, 15(1-2), 1995, pp. 144-144
57. BUSTILLO J; BUCHANAN RW; CARPENTER WT
    PRODROMAL SYMPTOMS VS EARLY WARNING SIGNS AND CLINICAL ACTION IN SCHIZOPHRENIA
    Schizophrenia bulletin
    
    J. Bustillo et al., "PRODROMAL SYMPTOMS VS EARLY WARNING SIGNS AND CLINICAL ACTION IN SCHIZOPHRENIA", Schizophrenia bulletin, 21(4), 1995, pp. 553-559
58. LEHMAN AF; CARPENTER WT; GOLDMAN HH; STEINWACHS DM
    TREATMENT OUTCOMES IN SCHIZOPHRENIA - IMPLICATIONS FOR PRACTICE, POLICY, AND RESEARCH
    Schizophrenia bulletin
    
    A.F. Lehman et al., "TREATMENT OUTCOMES IN SCHIZOPHRENIA - IMPLICATIONS FOR PRACTICE, POLICY, AND RESEARCH", Schizophrenia bulletin, 21(4), 1995, pp. 669-675
59. CARPENTER WT
    SEROTONIN-DOPAMINE ANTAGONISTS AND TREATMENT OF NEGATIVE SYMPTOMS
    Journal of clinical psychopharmacology
    
    W.T. Carpenter, "SEROTONIN-DOPAMINE ANTAGONISTS AND TREATMENT OF NEGATIVE SYMPTOMS", Journal of clinical psychopharmacology, 15(1), 1995, pp. 30-35
60. WALTRIP RW; BUCHANAN RW; SUMMERFELT A; BREIER A; CARPENTER WT; BRYANT NL; RUBIN SA; CARBONE KM
    BORNA-DISEASE VIRUS AND SCHIZOPHRENIA
    Psychiatry research
    
    R.W. Waltrip et al., "BORNA-DISEASE VIRUS AND SCHIZOPHRENIA", Psychiatry research, 56(1), 1995, pp. 33-44
61. KIRKPATRICK B; CARPENTER WT
    DRUG DEVELOPMENT AND THE DEFICIT SYNDROME OF SCHIZOPHRENIA
    Biological psychiatry
    
    B. Kirkpatrick e W.T. Carpenter, "DRUG DEVELOPMENT AND THE DEFICIT SYNDROME OF SCHIZOPHRENIA", Biological psychiatry, 38(5), 1995, pp. 277-278
62. CARPENTER WT; TAMMINGA CA
    WHY NEUROLEPTIC WITHDRAWAL IN SCHIZOPHRENIA
    Archives of general psychiatry
    
    W.T. Carpenter e C.A. Tamminga, "WHY NEUROLEPTIC WITHDRAWAL IN SCHIZOPHRENIA", Archives of general psychiatry, 52(3), 1995, pp. 192-193
63. CARPENTER WT; CONLEY RR; BUCHANAN RW; BREIER A; TAMMINGA CA
    PATIENT RESPONSE AND RESOURCE-MANAGEMENT - ANOTHER VIEW OF CLOZAPINE TREATMENT OF SCHIZOPHRENIA
    The American journal of psychiatry
    
    W.T. Carpenter et al., "PATIENT RESPONSE AND RESOURCE-MANAGEMENT - ANOTHER VIEW OF CLOZAPINE TREATMENT OF SCHIZOPHRENIA", The American journal of psychiatry, 152(6), 1995, pp. 827-832
64. PULVER AE; KARAYIORGOU M; WOLYNIEC PS; LASSETER VK; KASCH L; NESTADT G; ANTONARAKIS S; HOUSMAN D; KAZAZIAN HH; MEYERS D; OTT J; LAMACZ M; LIANG KY; HANFELT J; ULLRICH G; DEMARCHI N; RAMU E; MCHUGH PR; ADLER L; THOMAS M; CARPENTER WT; MANSCHRECK T; GORDON CT; KIMBERLAND M; BABB R; PUCK J; CHILDS B
    SEQUENTIAL STRATEGY TO IDENTIFY A SUSCEPTIBILITY GENE FOR SCHIZOPHRENIA - REPORT OF POTENTIAL LINKAGE ON CHROMOSOME 22Q12-Q13.1 .1.
    American journal of medical genetics
    
    A.E. Pulver et al., "SEQUENTIAL STRATEGY TO IDENTIFY A SUSCEPTIBILITY GENE FOR SCHIZOPHRENIA - REPORT OF POTENTIAL LINKAGE ON CHROMOSOME 22Q12-Q13.1 .1.", American journal of medical genetics, 54(1), 1994, pp. 36-43
65. CARPENTER WT; BUCHANAN RW
    SCHIZOPHRENIA - REPLY
    The New England journal of medicine
    
    W.T. Carpenter e R.W. Buchanan, "SCHIZOPHRENIA - REPLY", The New England journal of medicine, 331(4), 1994, pp. 276-276
66. CARPENTER WT; BUCHANAN RW
    SCHIZOPHRENIA
    The New England journal of medicine
    
    W.T. Carpenter e R.W. Buchanan, "SCHIZOPHRENIA", The New England journal of medicine, 330(10), 1994, pp. 681-690
67. KIRKPATRICK B; BUCHANAN RW; BREIER A; CARPENTER WT
    DEPRESSIVE SYMPTOMS AND THE DEFICIT SYNDROME OF SCHIZOPHRENIA
    The Journal of nervous and mental disease
    
    B. Kirkpatrick et al., "DEPRESSIVE SYMPTOMS AND THE DEFICIT SYNDROME OF SCHIZOPHRENIA", The Journal of nervous and mental disease, 182(8), 1994, pp. 452-455
68. BUCHANAN RW; CARPENTER WT
    DOMAINS OF PSYCHOPATHOLOGY - AN APPROACH TO THE REDUCTION OF HETEROGENEITY IN SCHIZOPHRENIA
    The Journal of nervous and mental disease
    
    R.W. Buchanan e W.T. Carpenter, "DOMAINS OF PSYCHOPATHOLOGY - AN APPROACH TO THE REDUCTION OF HETEROGENEITY IN SCHIZOPHRENIA", The Journal of nervous and mental disease, 182(4), 1994, pp. 193-204
69. LIDDLE P; CARPENTER WT; CROW T
    SYNDROMES OF SCHIZOPHRENIA CLASSIC LITERATURE
    British Journal of Psychiatry
    
    P. Liddle et al., "SYNDROMES OF SCHIZOPHRENIA CLASSIC LITERATURE", British Journal of Psychiatry, 165, 1994, pp. 721-727
70. CARPENTER WT; BUCHANAN RW; KIRKPATRICK B; TAMMINGA C; WOOD F
    NEURAL CIRCUITS IN SCHIZOPHRENIA
    Archives of general psychiatry
    
    W.T. Carpenter et al., "NEURAL CIRCUITS IN SCHIZOPHRENIA", Archives of general psychiatry, 51(7), 1994, pp. 516-516
71. BUCHANAN RW; STRAUSS ME; KIRKPATRICK B; HOLSTEIN C; BREIER A; CARPENTER WT
    NEUROPSYCHOLOGICAL IMPAIRMENTS IN DEFICIT VS NONDEFICIT FORMS OF SCHIZOPHRENIA
    Archives of general psychiatry
    
    R.W. Buchanan et al., "NEUROPSYCHOLOGICAL IMPAIRMENTS IN DEFICIT VS NONDEFICIT FORMS OF SCHIZOPHRENIA", Archives of general psychiatry, 51(10), 1994, pp. 804-811
72. CARPENTER WT
    THE DEFICIT SYNDROME
    The American journal of psychiatry
    
    W.T. Carpenter, "THE DEFICIT SYNDROME", The American journal of psychiatry, 151(3), 1994, pp. 327-329
73. BREIER A; BUCHANAN RW; KIRKPATRICK B; DAVIS OR; IRISH D; SUMMERFELT A; CARPENTER WT
    EFFECTS OF CLOZAPINE ON POSITIVE AND NEGATIVE SYMPTOMS IN OUTPATIENTSWITH SCHIZOPHRENIA
    The American journal of psychiatry
    
    A. Breier et al., "EFFECTS OF CLOZAPINE ON POSITIVE AND NEGATIVE SYMPTOMS IN OUTPATIENTSWITH SCHIZOPHRENIA", The American journal of psychiatry, 151(1), 1994, pp. 20-26
74. CARPENTER WT; BENES F; CARLSSON A; TAMMINGA C; WEINBERGER DR; GRACE AA
    INTERACTIVE DISCUSSION OF SCHIZOPHRENIA
    Neuropsychopharmacology
    
    W.T. Carpenter et al., "INTERACTIVE DISCUSSION OF SCHIZOPHRENIA", Neuropsychopharmacology, 9(2), 1993, pp. 190000053-190000054
75. ANDREASEN NC; CARPENTER WT
    DIAGNOSIS AND CLASSIFICATION OF SCHIZOPHRENIA
    Schizophrenia bulletin
    
    N.C. Andreasen e W.T. Carpenter, "DIAGNOSIS AND CLASSIFICATION OF SCHIZOPHRENIA", Schizophrenia bulletin, 19(2), 1993, pp. 199-214
76. KIRKPATRICK B; BUCHANAN RW; BREIER A; CARPENTER WT
    CASE IDENTIFICATION AND STABILITY OF THE DEFICIT SYNDROME OF SCHIZOPHRENIA
    Psychiatry research
    
    B. Kirkpatrick et al., "CASE IDENTIFICATION AND STABILITY OF THE DEFICIT SYNDROME OF SCHIZOPHRENIA", Psychiatry research, 47(1), 1993, pp. 47-56
77. CARPENTER WT
    PSYCHOSOCIAL TREATMENT OF SCHIZOPHRENIA - COMMENTARY
    Psychiatry
    
    W.T. Carpenter, "PSYCHOSOCIAL TREATMENT OF SCHIZOPHRENIA - COMMENTARY", Psychiatry, 56(3), 1993, pp. 301-306
78. BREIER A; BUCHANAN RW; IRISH D; CARPENTER WT
    CLOZAPINE TREATMENT OF OUTPATIENTS WITH SCHIZOPHRENIA - OUTCOME AND LONG-TERM RESPONSE PATTERNS
    Hospital & community psychiatry
    
    A. Breier et al., "CLOZAPINE TREATMENT OF OUTPATIENTS WITH SCHIZOPHRENIA - OUTCOME AND LONG-TERM RESPONSE PATTERNS", Hospital & community psychiatry, 44(12), 1993, pp. 1145-1149
79. CARPENTER WT; BUCHANAN RW; KIRKPATRICK B; TAMMINGA C; WOOD F
    STRONG INFERENCE, THEORY TESTING, AND THE NEUROANATOMY OF SCHIZOPHRENIA
    Archives of general psychiatry
    
    W.T. Carpenter et al., "STRONG INFERENCE, THEORY TESTING, AND THE NEUROANATOMY OF SCHIZOPHRENIA", Archives of general psychiatry, 50(10), 1993, pp. 825-831